Patent Assignment
Reel/Frame 048102/0478
Assignment of Assignor's Interest
Recorded: 2018-10-24
Pages: 83
Assignor
OREXIGEN THERAPEUTICS, INC.
Executed: 2018-07-13
Assignee
NALPROPION PHARMACEUTICALS, INC.
10 NORTH PARK PLACE, SUITE 201, MORRISTOWN, NEW JERSEY, 07960
Covered Property
(1)
Increasing Drug Bioavailability in Naltrexone Therapy
Application:
13/991,137 →
Publication:
US 2013/0245056
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 20, 2017
From: FLANAGAN, SHAWN
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041646/0415 →
Assignment of Assignor's Interest
Mar 20, 2017
From: DUNAYEVICH, EDUARDO
To: OREXIGEN THERAPEUTICS, INC.
Reel/Frame 041648/0415 →
Security Interest
Aug 6, 2018
From: NALPROPION PHARMACEUTICALS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 047288/0321 →
Release of Security Interest
Sep 27, 2019
From: WILMINGTON SAVINGS FUND SOCIETY, FSB
To: NALPROPION PHARMACEUTICALS, INC.
Reel/Frame 050574/0106 →